SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rationally designed molecular glue ...
The tumor begins before birth. Somewhere in the developing fetus, neural crest cells that should have matured into adrenal tissue or sympathetic ganglia take a wrong turn, and a child is born ...
In 2017, Stephanie Uy learned that her 22-month-old daughter, Aspen, had stage IV high-risk neuroblastoma. The cancer, which develops from the sympathetic nervous system, is the most common type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results